Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
KMDA · NASDAQ · Pharmaceutical Preparations · Foreign private issuer
$7.74−0.09 (−1.15%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Kamada (KMDA) · oqro.io/stocks/KMDA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
ARK Investment Management disclosed a reduced position in KMDA for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 12, 2026
ARK Investment Management disclosed a new position in KMDA for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 11, 2026
ARK Investment Management no longer reported KMDA for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 12, 2025
ARK Investment Management disclosed an increased position in KMDA for Q3 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Jul 30, 2025
ARK Investment Management disclosed a new position in KMDA for Q2 2025Source